Valuation check: TMO's profit margin is 15.06%, above the Healthcare sector average of 14.41%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
As of the most recent data (June 2026), TMO shows a profit margin of 15.06%. That compares with 15.24% in the prior-year period — down 1.2% year over year. That is above the Healthcare sector average of 14.41%. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, TMO's profit margin is now 15.06% (was 15.24%) — a 1.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Thermo Fisher Scientific is outperforming or lagging.
The Healthcare sector average profit margin is about 14.41%. Thermo Fisher Scientific is at 15.06%, which is higher that average. That is roughly 4.5% above the sector mean. Use the comparison chart on this page to see how TMO stacks up against individual peers as well.
That compares with 15.24% in the prior-year period — down 1.2% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Thermo Fisher Scientific with peers to see if the move is company-specific or sector-wide.
Besides this profit margin page, Stockcircle has Thermo Fisher Scientific's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 15.06%) with ownership activity and broader fundamentals.